Page last updated: 2024-09-05

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Granuloma Gangraenescens

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide has been researched along with Granuloma Gangraenescens in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ALAJMO, E; ARSLAN, M; CHERUBINO, M; FERRERI, G; NEUSS, O1

Other Studies

1 other study(ies) available for n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Granuloma Gangraenescens

ArticleYear
[ARE GRANULOMA GANGRAENESCENS, THE WEGENER SYNDROME AND THE CEPHALIC LOCALIZATION OF PANARTERITIS NODOSA TO BE CONSIDERED AS 3 DIFFERENT DISEASES OR 3 CLINICAL FORMS OF THE SAME DISEASE?].
    Minerva otorinolaringologica, 1963, Volume: 13

    Topics: Classification; Cyclic N-Oxides; Granuloma, Lethal Midline; Granulomatosis with Polyangiitis; Humans; Levamisole; Polyarteritis Nodosa

1963